Pandey to Reclaim Full Control of AIMS Hospital Chain

Pandey to Reclaim Full Control of AIMS Hospital Chain

The AIMS Hospital stake buyback represents a significant shift in the ownership structure of one of Faridabad’s leading healthcare facilities. Specifically, Dr. Narendra Pandey, the founder of the Asian Institute of Medical Sciences (AIMS), is set to repurchase a 49% stake. 360 ONE Asset will provide approximately ₹600 crore to facilitate this transaction. Consequently, this move will allow Pandey to consolidate his control over the 450-bed hospital chain.

Details of the AIMS Hospital Stake Buyback

The asset management firm, 360 ONE, is currently finalizing the loan for the share repurchase. Currently, British International Investment (BII) and OrbiMed hold these stakes within Blue Sapphire Healthcare. Furthermore, the total valuation of the hospital sits at approximately ₹1,200 crore. Therefore, the deal effectively ends the tenure of these private equity investors in the entity. Pandey previously explored several funding avenues including KKR and Kotak before settling on 360 ONE. Moreover, Alvarez & Marsal served as the financial advisor for this fundraising process.

Strategic Growth in Indian Healthcare

Hospital valuations in India have remained exceptionally high recently. In fact, many standalone hospitals now command multiples of 25-30 times their earnings. Because of these robust valuations, many Indian promoters now prefer using structured credit to regain ownership. For instance, recent buybacks at firms like InMobi and Zepto highlight this growing trend. Additionally, the healthcare delivery sector continues to attract significant deal activity. Consequently, analysts recorded $12.4 billion in transactions throughout 2025. This surge marks a 35% increase compared to the previous year. Meanwhile, refinancing and capital expenditure funding remain key drivers for these large-scale investments. Professionals looking to enhance their skills in managing large healthcare systems or complex financial transactions within medicine might consider specialized training, such as the Certification Course In General Practice or programs focusing on healthcare finance.

Frequently Asked Questions

Q1: Who are the primary investors exiting AIMS?

British International Investment (BII) and OrbiMed are the private equity firms selling their 49% stake back to the founder.

Q2: What is the current valuation of the Asian Institute of Medical Sciences?

The hospital chain is currently valued at roughly ₹1,200 crore, reflecting the high demand for healthcare assets in India.

Q3: How is the buyback being financed?

The buyback is being financed through approximately ₹600 crore in credit provided by 360 ONE Asset.

References

1. 360 ONE to finance AIMS founder’s stake buyback – ETHealthworld
2. EY Report: Indian Healthcare Transaction Trends 2025
3. India Healthcare Delivery Sector Outlook – CRISIL Reports

Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.